Neue Suche | Kongressdetail
mail
Druckansicht
 
 

HER2-Targeted Therapies Summit 2022

Evvnt Promotion / evvnt
Archiv
-
14.06.2022 - 16.06.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 09:00 - 17:00
 
Kongressthemen
The momentum in anti-HER2 drug development is exploding:

Outcomes for HER2-expressing breast cancer are patients constantly improving; diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 'low' space and wider range of tumor indications; the last year has given us more progress in HER2-targeted therapies than ever before.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Cecile Geuijen Chief Scientific Officer and Vice President - Oncology, Merus, Shane Olwill Chief Development Officer, Senior Vice President and Head of Translational Science, Pieris Pharmaceuticals and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1003520-2?pid=4832
Frau Ellie Saunders
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Industry Pricing - Conference + Workshop Day - Standard Rate: USD 4097.0, Industry Pricing - Conference Only - Standard Rate: USD 2899.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

newTreeSwiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.Charité International AcademyEuropean Health Forum GasteinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärzte der WeltHilfswerk Austria